Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 5Phase 3 4Phase 1/2 2Phase 4 1Phase 1 1

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 667INDUSTRY 148NIH 80NETWORK 19OTHER_GOV 5FED 1

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 149Thoracic 82Breast 76Gynecologic 34Lymphoid 30Head & Neck 26Other hematologic neoplasm 17Genitourinary 16Dermatologic 13Sarcoma 11Tumor-Agnostic 8CNS 7Other solid neoplasm 6Endocrine 6Plasma cell 5NET 5Myeloid 5Classical hematology 3Other neoplasm 1Other 1

Conditions

Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Papillomavirus Infections 1Lymphoma, Large B-Cell, Diffuse 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

treosulfan 1nilotinib 1cc-486 1Human Papillomavirus Recombinant Vaccine nonavalent 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 2 × OTHER_GOV × Myeloid × Clear all
NCT06793410 2025-06-05

Vaccination Against Human Papillomavirus (HPV) After Allogeneic Stem Cell Transplantation

Vastra Gotaland Region

Phase 2 Recruiting
100 enrolled
LymphoidMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Lymphoma, Large B-Cell, Diffuse, Papillomavirus Infections

NCT03493646 2024-05-28

Evaluating in Vivo AZA Incorporation in Mononuclear Cells Following Vidaza or CC486

Kirby Institute

Phase 2 Completed
40 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic

NCT00750659 2016-04-20

Nilotinib Pre and Post Allogeneic Stem Cell Transplantation

Sheba Medical Center

Phase 2 Completed
24 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01542944 2016-04-20

TevaGastrim for Stem Cell Mobilization Sibling Donors

Sheba Medical Center

Phase 2 Completed
24 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

NCT00491634 2015-12-02

Treosulfan-based Conditioning for Transplantation in AML/MDS

Sheba Medical Center

Phase 2 Completed
24 enrolled
MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡